Am J Perinatol 2007; 24(8): 497-500
DOI: 10.1055/s-2007-986684
© Thieme Medical Publishers

Expression of Calcitonin Gene-Related Peptide-Receptor Component Protein (CGRP-RCP) in Human Myometrium in Differing Physiological States and Following Misoprostol Administration

Nina Goharkhay1 , Jing Lu2 , Juan C. Felix3 , Deborah A. Wing4
  • 1Department of Obstetrics and Gynecology, University of Texas Medical Branch Galveston, Galveston, Texas
  • 2Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, California
  • 3Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California
  • 4Department of Obstetrics and Gynecology, University of California at Irvine, Orange, California
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
12. September 2007 (online)

ABSTRACT

Our objective was to assess relative expression levels of mRNA for calcitonin gene-related peptide-receptor component protein (CGRP-RCP) in human myometrium in various physiological states. Using semiquantitative reverse transcriptase polymerase chain reaction (RT-PCR), we analyzed myometrial samples from 46 women (10 menopausal, 10 nongravid premenopausal, 19 gravidae, and 7 premenopausal misoprostol-treated nongravid women) for the specific expression of CGRP-RCP mRNA. The expression of CGRP-RCP was significantly increased in gravid compared with nongravid myometrium (p < 0.002). No significant differences in CGRP-RCP expression were found among the other study groups. We concluded that the increased mRNA expression CGRP-RCP in gravid myometrium supports the possibility of involvement of CGRP in the control of myometrial contractility. Additional studies are necessary to evaluate the exact mechanism of action of CGRP and CGRP-RCP in human myometrium.

REFERENCES

  • 1 Olson D M, Mijovic J E, Sadowsky D W. Control of human parturition.  Semin Perinatol. 1995;  19 52-63
  • 2 Cibils L A. Contractility of the nonpregnant human uterus.  Obstet Gynecol. 1967;  30 441-461
  • 3 Akerlund M. Pathophysiology of dysmenorrhea.  Acta Obstet Gynecol Scand Suppl. 1979;  87 27-32
  • 4 Maggi M, Baldi E, Susini T. Hormonal and local regulation of uterine activity during parturition: part II-the prostaglandin and adrenergic systems.  J Endocrinol Invest. 1994;  17 757-770
  • 5 Russell J A, Leng G. Sex, parturition and motherhood without oxytocin?.  J Endocrinol. 1998;  157 343-359
  • 6 Helmer H, Hackl T, Schneeberger C et al.. Oxytocin and vasopressin 1a receptor gene expression in the cycling or pregnant human uterus.  Am J Obstet Gynecol. 1998;  179 1572-1578
  • 7 Goharkhay N, Wing D A, Pan V et al.. The expression of EP3-6 and inducible nitric oxide synthase messenger RNA are correlated in pregnant and misoprostol-treated but not in nongravid or menopausal myometrium.  Am J Obstet Gynecol. 2002;  186 1202-1206
  • 8 Elovitz M A, Ascher-Landsberg J, Saunders T, Phillippe M. The mechanisms underlying the stimulatory effects of thrombin on myometrial smooth muscle.  Am J Obstet Gynecol. 2000;  183 674-681
  • 9 Yallampalli C, Chauhan M, Thota C S, Kondapaka S, Wimalawansa S J. Calcitonin gene-related peptide in pregnancy and its emerging receptor heterogeneity.  Trends Endocrinol Metab. 2002;  13 263-269
  • 10 Prado M A, Evans-Bain B, Dickerson I M. Receptor component protein (RCP): a member of a multi-protein complex required for G-protein-coupled signal transduction.  Biochem Soc Trans. 2002;  30 460-464
  • 11 Nikitenko L L, Brown N S, Smith D M, MacKenzie I Z, Bicknell R, Rees M C. Differential and cell-specific expression of calcitonin receptor-like receptor and receptor activity modifying proteins in the human uterus.  Mol Hum Reprod. 2001;  7 655-664
  • 12 Fernandez H L, Chen M, Nadelhaft I, Durr J A. Calcitonin gene-related peptides: their binding sites and receptor accessory proteins in adult mammalian skeletal muscles.  Neuroscience. 2003;  119 335-345
  • 13 Thota C, Gangula P R, Dong Y L, Yallampalli C. Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments.  Biol Reprod. 2003;  69 1432-1437
  • 14 Luebke A E, Dahl G P, Roos B A, Dickerson I M. Identification of a protein that confers calcitonin gene-related peptide responsiveness to oocytes by using a cystic fibrosis transmembrane conductance regulator assay.  Proc Natl Acad Sci USA. 1996;  93 3455-3460
  • 15 Rozen S, Skaletsky H J. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S Bioinformatics Methods and Protocols: Methods in Molecular Biology (2000). Humana Press Totowa, NJ; 365-386

Nima GoharkhayM.D. 

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology

University of Texas Medical Branch Galveston, Galveston, TX 77555-0587; reprints not available from the authors

    >